Verrica Pharmaceuticals (VRCA) Q2 2024 Earnings

13MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.56
-0.44
-0.33
-0.21

Details

Expected EPS
-0.44695
Actual EPS
-0.44
Surprise EPS
0.01
Surprise Percent
+1.55%

Description

Verrica Pharmaceuticals (VRCA) has reported earnings of -0.44 per share for Q2 2024.

0 Comments

Share your thoughts